Nature4 年
Medivir—focusing on cancer one prodrug at a time
The company’s therapeutic strategy consists of designing tumor-directed nucleotide prodrugs. Once taken up by the tumor cells, the nucleotide prodrugs are cleaved, and the nucleotides can ...
来自MSN12 天
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
FiercePharma14 天
Supernus' 4th try proves the charm with long-awaited FDA approval for Parkinson's infusion ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is meant to allow patients more control over their "off" time, or the instances ...
Nasdaq14 天
FDA Approves ONAPGO Apomorphine Hydrochloride For Parkinson's Disease Treatment
(RTTNews) - Supernus Pharmaceuticals, Inc. (SUPN), a biopharmaceutical company, announced on Tuesday the FDA approval of ONAPGO or apomorphine hydrochloride for the treatment of motor fluctuations ...
Nasdaq14 天
Supernus Pharmaceuticals Announces FDA Approval of ONAPGO, the First Subcutaneous ...
Supernus Pharmaceuticals has announced the FDA approval of ONAPGO, the first subcutaneous apomorphine infusion device specifically designed to treat motor fluctuations in adults with advanced ...
Yahoo Finance12 天
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride ... subcutaneous infusion therapy combining prodrugs of carbidopa and levodopa, was approved ...